DK0980374T3 - Phosphodiesterase 4-inhiberende diazepinoindoloner. - Google Patents
Phosphodiesterase 4-inhiberende diazepinoindoloner.Info
- Publication number
- DK0980374T3 DK0980374T3 DK98925598T DK98925598T DK0980374T3 DK 0980374 T3 DK0980374 T3 DK 0980374T3 DK 98925598 T DK98925598 T DK 98925598T DK 98925598 T DK98925598 T DK 98925598T DK 0980374 T3 DK0980374 T3 DK 0980374T3
- Authority
- DK
- Denmark
- Prior art keywords
- formula
- compounds
- phosphodiesterase
- diazepinoindolones
- inhibiting
- Prior art date
Links
- MSYGAHOHLUJIKV-UHFFFAOYSA-N 3,5-dimethyl-1-(3-nitrophenyl)-1h-pyrazole-4-carboxylic acid ethyl ester Chemical compound CC1=C(C(=O)OCC)C(C)=NN1C1=CC=CC([N+]([O-])=O)=C1 MSYGAHOHLUJIKV-UHFFFAOYSA-N 0.000 title abstract 2
- 102000011017 Type 4 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 title abstract 2
- 108010037584 Type 4 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 title abstract 2
- ZWOMUDQWODQGQH-UHFFFAOYSA-N 1H-pyrrolo[2,3-g][1,2]benzodiazepin-2-one Chemical class C1=CC2=NN=CC=CC2=C2C1=CC(=O)N2 ZWOMUDQWODQGQH-UHFFFAOYSA-N 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 206010065687 Bone loss Diseases 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 206010067125 Liver injury Diseases 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 231100000753 hepatic injury Toxicity 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000002815 pulmonary hypertension Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9705422A FR2762841B1 (fr) | 1997-04-30 | 1997-04-30 | Diazepino-indolones inhibitrices de phosphodiesterases iv |
| PCT/EP1998/002827 WO1998049169A1 (en) | 1997-04-30 | 1998-04-30 | Phosphodiesterase 4-inhibiting diazepinoindolones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0980374T3 true DK0980374T3 (da) | 2003-05-05 |
Family
ID=9506517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98925598T DK0980374T3 (da) | 1997-04-30 | 1998-04-30 | Phosphodiesterase 4-inhiberende diazepinoindoloner. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6239130B1 (OSRAM) |
| EP (1) | EP0980374B1 (OSRAM) |
| JP (1) | JP2001522367A (OSRAM) |
| KR (1) | KR20010020386A (OSRAM) |
| AT (1) | ATE232534T1 (OSRAM) |
| AU (1) | AU729495B2 (OSRAM) |
| BR (1) | BR9809429A (OSRAM) |
| CA (1) | CA2278217A1 (OSRAM) |
| DE (1) | DE69811360T2 (OSRAM) |
| DK (1) | DK0980374T3 (OSRAM) |
| ES (1) | ES2190083T3 (OSRAM) |
| FR (1) | FR2762841B1 (OSRAM) |
| HR (1) | HRP980231B1 (OSRAM) |
| MX (1) | MXPA99006979A (OSRAM) |
| NZ (1) | NZ337589A (OSRAM) |
| WO (1) | WO1998049169A1 (OSRAM) |
| ZA (1) | ZA983704B (OSRAM) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2795731B1 (fr) * | 1999-07-02 | 2001-09-07 | Warner Lambert Co | PROCEDE DE PREPARATION DE [1,4] DIAZEPINO [6,7,1-hi] INDOL-4-ONES SUBSTITUEES |
| CA2401697A1 (en) * | 2000-03-03 | 2001-09-07 | Pfizer Products Inc. | Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| EP1161949A1 (en) | 2000-06-09 | 2001-12-12 | Warner-Lambert Company | Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease |
| EP1199074A1 (en) * | 2000-09-15 | 2002-04-24 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| EP1188438A1 (en) * | 2000-09-15 | 2002-03-20 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
| WO2002094321A1 (en) * | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | Compositions for promoting healing of bone fracture |
| WO2002094320A1 (en) | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | Therapeutic compositions for repairing chondropathy |
| AU2002317377A1 (en) * | 2001-07-20 | 2003-03-03 | Cancer Research Technology Limited | Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| US20050187278A1 (en) * | 2003-08-28 | 2005-08-25 | Pharmacia Corporation | Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors |
| US20090042951A1 (en) * | 2004-02-20 | 2009-02-12 | Robert Danziger | Blood Pressure Reduction in Salt-Sensitive Hypertension |
| WO2005102317A1 (en) * | 2004-04-23 | 2005-11-03 | Celgene Corporation | Methods of using and compositions comprising pde4 modulators for the treatment and management of pulmonary hypertension |
| BRPI0610498A2 (pt) * | 2005-04-19 | 2010-06-22 | Nycomed Gmbh | uso de roflumilast,composição farmacêutica, produto de combinação e kit para o tratamento de hipertensão pulmonar |
| CA2663436A1 (en) * | 2006-10-04 | 2008-04-10 | Pfizer Products Inc. | Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists |
| RU2009141592A (ru) * | 2007-04-11 | 2011-05-20 | Алькон Рисерч, Лтд. (Us) | ПРИМЕНЕНИЕ ИНГИБИТОРА TNFα В СОЧЕТАНИИ С АНТИГИСТАМИННЫМ СРЕДСТВОМ ДЛЯ ЛЕЧЕНИЯ АЛЛЕРГИЧЕСКОГО РИНИТА И АЛЛЕРГИЧЕСКОГО КОНЪЮНКТИВИТА |
| US20090182035A1 (en) * | 2007-04-11 | 2009-07-16 | Alcon Research, Ltd. | Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis |
| US20090005381A1 (en) * | 2007-06-26 | 2009-01-01 | Philip Manton Brown | Methods of treating serotonin-mediated diseases and disorders |
| RU2012117141A (ru) * | 2009-10-01 | 2013-11-10 | Алькон Рисерч, Лтд. | Композиции олопатадина и способы их применения |
| US12472241B2 (en) | 2018-12-28 | 2025-11-18 | Regeneron Pharmaceuticals, Inc. | Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2725719B1 (fr) * | 1994-10-14 | 1996-12-06 | Jouveinal Inst Rech | Diazepino-indoles inhibiteurs de phosphodiesterases iv |
-
1997
- 1997-04-30 FR FR9705422A patent/FR2762841B1/fr not_active Expired - Fee Related
-
1998
- 1998-04-29 HR HR980231A patent/HRP980231B1/xx not_active IP Right Cessation
- 1998-04-30 EP EP98925598A patent/EP0980374B1/en not_active Expired - Lifetime
- 1998-04-30 DE DE69811360T patent/DE69811360T2/de not_active Expired - Fee Related
- 1998-04-30 US US09/380,883 patent/US6239130B1/en not_active Expired - Fee Related
- 1998-04-30 NZ NZ337589A patent/NZ337589A/xx unknown
- 1998-04-30 AU AU77652/98A patent/AU729495B2/en not_active Ceased
- 1998-04-30 BR BR9809429-7A patent/BR9809429A/pt not_active IP Right Cessation
- 1998-04-30 AT AT98925598T patent/ATE232534T1/de not_active IP Right Cessation
- 1998-04-30 JP JP54662498A patent/JP2001522367A/ja not_active Abandoned
- 1998-04-30 MX MXPA99006979A patent/MXPA99006979A/es unknown
- 1998-04-30 WO PCT/EP1998/002827 patent/WO1998049169A1/en not_active Ceased
- 1998-04-30 DK DK98925598T patent/DK0980374T3/da active
- 1998-04-30 ES ES98925598T patent/ES2190083T3/es not_active Expired - Lifetime
- 1998-04-30 KR KR1019997010008A patent/KR20010020386A/ko not_active Ceased
- 1998-04-30 ZA ZA9803704A patent/ZA983704B/xx unknown
- 1998-04-30 CA CA002278217A patent/CA2278217A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ337589A (en) | 2000-10-27 |
| EP0980374A1 (en) | 2000-02-23 |
| FR2762841B1 (fr) | 1999-07-02 |
| ATE232534T1 (de) | 2003-02-15 |
| HRP980231B1 (en) | 2002-06-30 |
| AU7765298A (en) | 1998-11-24 |
| JP2001522367A (ja) | 2001-11-13 |
| FR2762841A1 (fr) | 1998-11-06 |
| AU729495B2 (en) | 2001-02-01 |
| US6239130B1 (en) | 2001-05-29 |
| MXPA99006979A (es) | 2005-04-19 |
| CA2278217A1 (en) | 1998-11-05 |
| BR9809429A (pt) | 2000-06-13 |
| HRP980231A2 (en) | 2000-04-30 |
| ES2190083T3 (es) | 2003-07-16 |
| DE69811360D1 (de) | 2003-03-20 |
| DE69811360T2 (de) | 2003-10-09 |
| WO1998049169A1 (en) | 1998-11-05 |
| ZA983704B (en) | 1999-10-25 |
| KR20010020386A (ko) | 2001-03-15 |
| EP0980374B1 (en) | 2003-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9809429A (pt) | Diazepinoindolonas inibidoras de fosfodiesterase 4 | |
| FI945557A0 (fi) | Isoksatsoliiniyhdisteet tulehduksenvastaisina aineina | |
| ATE187447T1 (de) | 3-phenyl-2-isoxazoline derivate als entzündugshemmende mittel | |
| EP1034164A4 (en) | BETA-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS | |
| AU2019502A (en) | Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto | |
| IL132398A0 (en) | Piperazine derivatives and their use as anti-inflammatory agents | |
| ZA9810735B (en) | Novel benzenesulfonamide inhibitors of pde-iv and their therapeutic use | |
| MX9805016A (es) | INHIBIDORES DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1 beta. | |
| AU2721402A (en) | Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto | |
| DK0749428T3 (da) | Isooxazolinforbindelser som inhibitorer af TNF-frigivelse | |
| BR0009869A (pt) | Método para inibir a produção e/ou secreção de citoquina, e, composição farmacêutica | |
| DK0873340T3 (da) | Heterocyklisk substituerede cyclopentanforbindelser | |
| BG104138A (en) | 2-aminopyridines containing substituents with condensed rings as nos inhibitors | |
| DE69905476D1 (en) | Phosphonsaürederivate als ptp-1b-inhibitoren | |
| AP2000001992A0 (en) | Succinamide inhibitors of inteleukin-1B converting enzyme. | |
| BR9907655A (pt) | Derivados de ácido di-hidróxi-hexanóico | |
| BG104292A (en) | Methods and compositions for the treatment of rheumatoid arthritis | |
| PT1294729E (pt) | 2-aminoalquil-tieno[2,3-d]pirimidinas | |
| DK0752990T3 (da) | Benzisothiazolderivater som inhibitorer af 5-lipoxygenasebiosyntese |